Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Incyte Corporation
Incyte Corporation
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Incyte Corporation
Incyte Corporation
INSYS Therapeutics Inc